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Acute exposure to inhaled ambient particles is
associated worldwide with adverse health
effects (1). The fraction of ultraﬁne particles
(UFPs) in the ambient aerosol is considered
as a major factor contributing to these effects
(2). Evidence for the involvement of chemi-
cally inert, very small particles in eliciting
adverse health effects comes from animal
experiments (3). The hypothesis that the
number of UFPs is more closely associated
with adverse health effects than the mass of
fine particles was recently supported in an
epidemiologic study (4). However, this
hypothesis remains controversial. The surface
area of particles might be another parameter
that determines the biologic response of tar-
get cells or tissues (5). To further elucidate
the role of ultraﬁne particles in adverse health
effects, we studied whether this particle frac-
tion acts on mediator systems involved in
physiologic responses of immune cells. 
Lipid mediators may play a major role in
promoting or eliciting responses of lung tissue
to air pollutants such as ozone (6,7), sulfur-
related species, especially sulfite (8,9), silica
(10,11), and residual oil ﬂy ash (12). Among
the lipid mediators, platelet-activating factor
and products of the 5-lipoxygenase (5-LO)
pathway such as leukotriene B4 (LTB4) are
known to stimulate immune cells such as
polymorphonuclear neutrophil (PMNs)
(13–15). By contrast, prostaglandin E2
(PGE2), a major product of the cyclooxyge-
nase (COX) pathway, counterbalances
inflammatory reactions by suppressing
defense functions of alveolar macrophages
(AMs) or PMNs (16–19). 
As part of the primary pulmonary defense
system, AMs are important target cells whose
major functions are a) the elimination of
inhaled particles such as pathogens and b)
the production of pro- and anti-inflamma-
tory mediators including leukotrienes and
prostaglandins. Related to these fundamental
functions, we tested the hypothesis that
UFPs and their agglomerates induce AMs to
release lipid mediators in a manner depen-
dent on the particle surface area, and that
the particle-induced release of some of these
mediators affects cellular defense mecha-
nisms such as the respiratory burst of
PMNs. We analyzed arachidonic acid (AA)
as a primary product of phospholipase A2
(PLA2), the COX-derived mediators PGE2,
thromboxane B2 (TXB2), 12-hydroxyhep-
tadecatrienoic acid (12-HHT), and the 5-LO
products LTB4 and 5-hydroxyeicosate-
traenoic acid (5-HETE). As model particles
we used agglomerates of ultrafine particles
(AUFPs) of elemental carbon (EC) and of
titanium dioxide (TiO2). The biologic effects
of these UFPs were compared with those of
agglomerates of ﬁne particles (AFPs) of TiO2. 
Materials and Methods
Materials
Phorbol 12-myristate 13-acetate (PMA) and
lucigenin were purchased from Sigma
(Deisenhofen, Germany); Polymorphprep
was from Nycomed (Oslo, Norway); phos-
phate-buffered saline (PBS) with or without
Ca2+/Mg2+ was from Biochrom (Berlin,
Germany); RPMI was from PAA
Laboratories (Linz, Austria); fetal calf serum,
penicillin, streptomycin and amphotericin
were from Life Technologies (Eggenstein,
Germany); [14C]-AA was from Amersham
Buchler (Braunschweig, Germany);
indomethacin (1-(p-chlorobenzoyl)-5-
methoxy-2-methyl-1H-indole-3-acetic acid)
and NS 398 (N-(2-cyclohexyloxy-4-nitro-
phenyl) methansulfonamide) were from
Calbiochem (Bad Soden, Germany); all other
chemicals (analytical or high-performance
chromatography grade) were from Merck
(Darmstadt, Germany).
Particle Characteristics
Ultrafine particles of EC were generated by
spark discharging according to the method
described by Roth et al. (20). The airborne
EC particles had a count median diameter of
77 nm and a specific surface area of 750 ±
150 m2/g (n = 50) as determined by adsorp-
tion of nitrogen (21). Ultraﬁne TiO2 particles
with a diameter of 21 nm and a speciﬁc sur-
face area of 50 m2/g were purchased from
Degussa (Frankfurt, Germany). The fine
TiO2 particles with a diameter of 250 nm
and a specific surface area of 6.5 m2/g were
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purchased from Fisher Scientiﬁc (Springﬁeld,
NJ, USA). 
Suspensions of ultraﬁne EC, ultraﬁne and
ﬁne TiO2 particles in PBS, pH 7.0, contain-
ing Ca2+/Mg2+ and 0.1 % glucose, were
prepared by repeated vortexing (5 times for 3
sec) and sonification (1 min) of the suspen-
sions. Despite the vigorous mixing, these par-
ticles formed agglomerates as determined by
microscopic determination. Therefore, during
incubation in suspension, the cells were
exposed to AFUPs and AFPs. 
Alveolar Macrophages
Canine AMs were harvested by bronchoalveo-
lar lavage of healthy beagles according to the
method of Maier et al. (22). Cells were recov-
ered by centrifugation (400 × g for 20 min)
and resuspended in PBS (without Ca2+/Mg2+).
Viability was more than 95% as determined by
trypan blue exclusion. By microscopic
examination of cytospin preparations after
May Grünwald Giemsa staining, 85–90% of
the cells were identiﬁed as AMs.
PMNs
Canine PMNs were isolated from citrate
blood samples of healthy beagles by density-
gradient centrifugation with Polymorphprep
according to Beck-Speier et al. (8). Blood (5
mL) was layered over Polymorphprep (5 mL)
diluted with 1.5% (w/v) NaCl. After cen-
trifugation (450× g for 30 min), separation
from lymphocytes/monocytes, and removal
of contaminating erythrocytes by hypotonic
lysis, a pure population of PMNs (99 ± 1%;
n = 3) was resuspended in PBS (without
Ca2+/Mg2+) containing 0.1% glucose.
Viability was more than 95% as estimated by
trypan blue exclusion.
AA Metabolites of AMs
Studies on the AA metabolism in particle-
treated AMs were performed as follows:
Canine AMs (1 × 106 /mL) were preincu-
bated for 2 hr at 37°C in RPMI medium con-
taining penicillin (100 U/mL), streptomycin
(100 U/mL), amphotericin B (2.5 µg/mL),
5% fetal calf serum, and labeled with [14C]-
AA (4 kBq/1 × 106 cells) in fresh medium for
20 hr. After removal of labeled medium and a
preincubation for 30 min at 37°C in PBS, pH
7, containing Ca2+/Mg2+ and 0.1% glucose,
AMs were incubated with particles for 60 min
at 37°C. Incubation was stopped by cooling
to 4°C and [14C]-lipids were extracted from a
1-mL suspension of AMs by addition of 3.75
mL chloroform/methanol (1:2). Phase separa-
tion was induced with an additional 1.25 mL
of chloroform and 1.25 mL of 0.2% formic
acid. The organic phase was collected, and the
aqueous phase was extracted once again with
chloroform (23). After drying the organic
phase under nitrogen, the metabolites were
dissolved in chloroform and spotted onto
high-performance thin-layer chromatography
(HPTLC) plates (10 cm × 20 cm Nano-
Durasil-20 glass plates; Macherey & Nagel,
Düren, Germany). Separation by thin-layer
chromatography (TLC) was processed in a
solvent system containing ethyl acetate/iso-
octane/acetic acid/water (10:5:2:10) according
to the method of Krug and Berndt (24).
[14C]-AA metabolites were visualized by
autoradiography. The Rf values of the
metabolites were determined by comparison
Figure 1. Autoradiogram of AA metabolites in AMs
treated with AUFP–EC and AUFP–TiO2. AMs (1 × 106
cells/mL) were incubated in the absence (control) and
presence of AUFP–EC (32 µg/mL) or AUFP–TiO2 (32
µg/mL), respectively. [14C]-AA metabolites were
extracted, separated by TLC, and visualized by autoradi-
ography as shown here, representative for all other incu-
bations of AMs with AUFP. The Rf values for the single
metabolites were 0.90 for AA, 0.66 for 12-HHT, 0.6 for
5-HETE, 0.49 for LTB4, 0.28 for PGE2, and 0.24 for TXB2.
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Figure 2. AM-derived generation of AA metabolites by AUFP–EC and their effect on the respiratory burst activity of PMNs. (A) [14C]-AA metabolites of AMs (1 × 106 cells/mL)
incubated with AUFP–EC were quantiﬁed by digital autoradiography. Data of the single metabolites (mean ± SD) are given as percentage of radioactivity of the metabolites of
control cells. Values of control metabolites represent the radioactivity of the single metabolites in relation to the total radioactivity of the control cells. The radioactivity as per-
centage of total radioactivity of control cells was 1.97 ± 0.58 [7] for arachidonic acid, 0.43 ± 0.08 [7] for 12-HHT, 0.32 ± 0.11 [7] for 5-HETE, 0.40 ± 0.14 [7] for LTB4, and 0.62 ± 0.21
[7] for PGE2/TXB2. Numbers in brackets represent the number of experiments performed with AMs of different dogs. Asterisks indicate significance of difference between
eicosanoid generation in control cells and particle-affected cells (*p < 0.05 and **p < 0.001). (B) Supernatants of AMs incubated in the absence (control) and presence of
AUFP–EC were analyzed for their ability to stimulate CL in PMNs. CL is given as percentages (means ± SD) of CL response of resting PMNs incubated with supernatant of control
AMs, which amounted to 3.031 ± 0.284 × 106 CL counts during 20 min per 1.5 × 104 cells [6]. Numbers in brackets represent the number of experiments performed with AM-
derived supernatants of different dogs. Asterisks indicate signiﬁcance of difference between CL of PMA-stimulated PMNs assayed with supernatant of control AMs and super-
natant of AMs incubated with particles (*p < 0.05 and **p < 0.001).
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with migration of [14C]-AA and commercial,
nonradioactive standards (LTB4, 5-HETE,
12-HHT, TXB2 and PGE2; Paesel and
Lorei, Hanau, Germany) visualized by phos-
phomolybdic acid (Macherey & Nagel) on
HPTLC plates. The radioactive metabolites
were quantiﬁed in relation to the total cellu-
lar radioactivity by digital autoradiography
(Berthold, Wildbad, Germany). Because
PGE2 and TXB2 showed identical Rf values
under this TLC, they were quantified as a
single band. 
Respiratory Burst Activity of PMNs by
AM-Derived Supernatants
Canine AMs (1 × 106/mL) were incubated for
60 min at 37°C in the absence (control) or
presence of particles in PBS, pH 7, containing
Ca2+/Mg2+ and 0.1% glucose. If the COX
inhibitors either indomethacin (50 µM) or
NS 398 (50 µM) were used, cells were prein-
cubated with these inhibitors for 20 min at
37°C followed by incubation with particles.
After centrifugation (400× g for 10 min) the
supernatants were isolated and their stimulat-
ing potential on respiratory burst activity of
PMNs was evaluated by lucigenin-dependent
chemiluminescence [CL; (25,26)]. Canine
PMNs (1.5 × 104/mL) were preincubated for
10 min at 37°C in a CL analyzer (Autolumat
LB 953, Berthold, Wildbad, Germany) in 250
µL PBS, pH 7, containing 0.1% glucose and
0.8 mM lucigenin. Aliquots (50 µL) of AM-
derived supernatants were added, and CL sig-
nals of PMNs were recorded for 20 min.
Subsequently, PMNs were stimulated by
PMA (50 ng), and CL was measured again for
20 min at 37°C. AM-derived supernatants of
individual canine donors were analyzed at
least in duplicate for their effect on respiratory
burst activity in PMNs.
Statistical Analysis
Statistical significance was determined by
analysis of variance and two-sample t-test
(STAT-SAK, Version 2.12 by G.E. Dallal,
1986, Malden, MA, USA). Changes with p ≤
0.05 were considered signiﬁcant.
Results
Generation of AA Metabolites by
Particle-Induced AMs and Their Effect
on Respiratory Burst Activity of PMNs 
The effects of AUFP–EC as well as that of
AUFP–TiO2 on the formation of AA and
the AA-derived COX metabolites 12-HHT
and PGE2/TXB2 and the 5-LO metabolites
5-HETE and LTB4 are seen in Figure 1.
These metabolites were quantified com-
pared to those of control cells. As shown in
Figure 2A, AUFP–EC at 1 µg/mL mass
concentration caused a 2-fold increase in
generation of AA as well as the COX prod-
ucts 12-HHT and PGE2/TXB2 by AMs
compared to control cells. The production
of the 5-LO products 5-HETE and LTB4
was enhanced at ≥ 10 µg/mL AUFP–EC, i.e.,
at 10-fold higher mass concentrations. There
was no further increase of eicosanoids at
AUFP–EC concentrations of 100 µg/mL or
320 µg/mL (data not shown). In addition we
assessed the inﬂuence of supernatants derived
from particle-treated AMs on PMN defense
function. Respiratory burst activity of PMA-
stimulated PMNs was reduced by super-
natants of AMs incubated with AUFP–EC
(Figure 2B). In contrast, there was no sup-
pressive effect on PMN respiratory burst
activity by supernatants obtained from con-
trol incubations with particles in absence of
AMs (data not shown). This suggests the
presence of an inhibitory factor produced by
AMs exposed to AUFP–EC. To study
whether COX metabolites are involved in
the inhibitory effect of AM-derived super-
natants, we pretreated AMs with the COX
inhibitors either indomethacin or NS 398
before particles were added. As seen in Table
1, supernatants from AM incubations with
AUFP–EC in the presence of COX
inhibitors did not reduce the respiratory
burst activity of PMN. 
AUFP–TiO2 induced AMs to generate
AA, 12-HHT, and PGE2/TXB2 at mass
concentrations ≥ 10 µg/mL (Figure 3A),
whereas the 5-LO products 5-HETE and
LTB4 were produced at mass concentrations
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Table 1. Inﬂuence of COX inhibitors on the PMN-inhibiting effect of supernatants derived form AUFP–treated AMs.a 
COX inhibitors used % CL of PMA-stimulated PMNs with supernatants derived from 
for AM preincubation Control AMs AUFP-EC–treated AMs AUFP-TiO2–treated AMs
No inhibitor 399 ± 21 289 ± 31* 257 ± 16*
Indomethacin 408 ± 26 396 ± 40 404 ± 52
NS 398 394 ± 38 406 ± 49 365 ± 45
aSupernatants of AMs (1 × 106 cells/mL) incubated in the absence (control) or presence of AUFP–EC (10 µg/mL) or AUFP–TiO2 (32
µg/mL) after preincubation with the COX inhibitors either indomethacin (50 µM) or NS 398 (50 µM), respectively, were analyzed for
their ability to activate CL of PMA-stimulated PMNs. Values are given as mean ± SD of three experiments performed with AMs of dif-
ferent dogs and represent percentages of CL response of resting PMNs in the presence of control supernatant (100% value) with 5.35
± 1.8 × 106 CL counts during 20 min per 1.5 × 104 cells (n = 3). Asterisks indicate signiﬁcant difference between CL response of PMA-
stimulated PMNs in the presence of control supernatant and CL response of PMA-stimulated PMNs in the presence of supernatant
from AUFP-treated AMs. *p < 0.05.
Figure 3. AM-derived generation of AA metabolites by AUFP–TiO2 and their effect on the respiratory burst activity of PMNs. (A) [14C]-AA metabolites of AMs (1 × 106 cells/mL)
incubated with AUFP–TiO2 were quantiﬁed according to legend for Figure 2A. The radioactivity as percentage of total radioactivity of control cells was 1.77 ± 0.53 [9] for AA, 0.40
± 0.14 [9] for 12-HHT, 0.26 ± 0.12 [9] for 5-HETE, 0.36 ± 0.18 [9] for LTB4, and 0.61 ± 0.31 [9] for PGE2/TXB2. (B) Supernatants of AMs incubated in the absence (control) and pres-
ence of AUFP–TiO2 were analyzed with PMNs according to legend for Figure 2B. The control value was 2.638 ± 0.469 × 106 CL counts during 20 min per 1.5 × 104 cells [9]. 
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≥ 32 µg/mL. The supernatants derived from
AMs incubated with AUFP–TiO2 reduced
respiratory burst activity of PMA-stimulated
PMNs (Figure 3B). This decrease of PMN
respiratory burst activity was not observed
with supernatants derived from AMs treated
with COX inhibitors prior to incubation with
AUFP–TiO2 (Table 1). 
AFP–TiO2 increased AA and the COX
products 12-HHT and PGE2/TXB2 in AMs
at mass concentrations of 100 µg/mL, and
the 5-LO products LTB4 and 5-HETE at
mass concentrations of 320 µg/mL (Figure
4A). These are markedly higher-particle mass
concentrations than those used for
AUFP–TiO2 to produce a similar effect. The
supernatants derived from AMs incubated
with AFP–TiO2 also reduced respiratory
burst activity of PMA-stimulated PMNs
(Figure 4B). 
Control experiments showed that the via-
bility of AMs after incubation with particles
did not change compared to that of control
cells (viability about 90 ± 2%, n = 2) as ascer-
tained by trypan blue exclusion. The particles
used in our study contained < 0.01% endo-
toxin as estimated by the Limulus amebocyte
lysate assay (Charles River, Sulzfeld,
Germany). Because endotoxin in various con-
centrations up to 10 µg/mL did not inﬂuence
the formation of eicosanoids in canine AMs,
a possible effect of an endotoxin contamina-
tion of the particles on the release of
eicosanoids can be excluded. 
Taken together our results indicate that
for each type of particle AA and the COX
products PGE2/TXB2 and 12-HHT are gen-
erated at distinctly lower particle mass con-
centrations than the 5-LO products. The
mediators present in the supernatants derived
from particle-treated AMs are able to suppress
PMN defense function. The mediators
responsible for inhibition of PMN activity are
COX dependent. 
Relationship between Eicosanoid
Production and Surface Area 
of the Particles
The particles used in this study have very dif-
ferent surface areas per mass. To evaluate
which parameter of the particles determines
the biologic response of AMs, we related the
data on the generation of eicosanoids to the
mass and surface area of the particles. As
shown in Table 2, a 2-fold initial increase of
AA, PGE2/TXB2, and 12-HHT by AMs was
seen at mass concentrations of 1 µg/mL for
AUFP–EC, 10 µg/mL for AUFP–TiO2, and
100 µg/mL for AFP–TiO2. However, these
different mass concentrations correspond to
very similar surface areas ranging between 5
and 7.5 cm2/mL for the three types of parti-
cles. This indicates that the initial release of
AA and the COX products PGE2/TXB2 and
12-HHT is induced by similar surface areas
of the different types of particles. Table 3
shows a 2-fold initial increase of the 5-LO
products LTB4 and 5-HETE by AMs incu-
bated with 10 µg/mL AUFP–EC, 32 µg/mL
AUFP–TiO2, and 320 µg/mL. These particle
mass concentrations correspond to surface
areas ranging between 16 and 75 cm2/mL.
Comparing both tables, it is apparent that the
5-LO products are released at higher particle
surface areas than AA and the COX products. 
Discussion
The present study demonstrates that
AUFP–EC, AUFP–TiO2, and AFP–TiO2
induce AMs to release AA as a metabolite of
PLA2, PGE2, TXA2 (detected as its inactive
metabolite TXB2), and 12-HHT as products
of the COX pathway, and LTB4 and
5-HETE as products of the 5-LO pathway.
However, the dose–response of the 5-LO
pathway to these particles is different from
that of the PLA2 and COX pathways. A 2-
fold release of PLA2- and COX-related
metabolites by AMs occurs at a mass concen-
tration of 1 µg/mL for AUFP–EC but at a
10-fold higher mass concentration for
AUFP–TiO2 and 100-fold higher mass con-
centration for AFP–TiO2 (Table 2). This ini-
tial increase of AA, 12-HHT, and
PGE2/TXB2 was followed by a further grad-
ual increase up to 300–400% of baseline level
for increasing particle mass concentrations
(Figures 2A, 3A, 4A). Interestingly, the very
different mass concentrations of the three types
of particles needed for the initial release of AA
and COX products correspond to similar sur-
face areas within a range of 5–7.5 cm2/mL
(Table 2). This implies that the surface area
rather than the mass concentration of the par-
ticles determines the biologic response of AMs
to the particles. This conclusion is supported
by ﬁndings of Oberdörster et al. (5) showing
that after instillation in rats the increased pul-
monary toxicity of ultraﬁne TiO2 particles was
related to their large surface area. Compared to
AA and the COX products, the initial increase
of the 5-LO–derived metabolites LTB4 and 5-
HETE is induced at substantially higher mass
concentrations for each type of particle corre-
sponding to surface areas ranging between 16
and 75 cm2/mL (Table 2). This indicates that
a higher particle surface area is needed for an
initial activation of the 5-LO pathway than for
that of PLA2 and the COX pathway. A further
increase of particle mass concentrations led to a
further increased release of 5-LO products up
to 500% of baseline level. At high surface area,
AUFP–TiO2 cause a stronger response on
Figure 4. AM-derived generation of AA metabolites by AFP–TiO2 and their effect on the respiratory burst activity of PMNs. (A) [14C]-AA metabolites of AMs (1 × 106 cells/mL)
incubated with AFP–TiO2 were quantiﬁed according to legend of Figure 2A. The radioactivity as percentage of total radioactivity of control cells was 1.78 ± 0.51 [7]for AA, 0.40 ±
0.14 [7] for 12-HHT, 0.22 ± 0.13 [7] for 5-HETE, 0.37 ± 0.19 [7] for LTB4, and 0.67 ± 0.41 [7] for PGE2/TXB2. (B) Supernatants of AMs incubated in the absence (control) and presence
of AFP–TiO2 were analyzed with PMNs according to legend for Figure 2B. The control value was 2.624 ± 0.488 × 106 CL counts during 20 min per 1.5 × 104 cells [7].
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eicosanoid release than AUFP–EC, which
might be due to the different chemical compo-
sition of both types of particles.
In our study the marked response of the
respiratory burst activity of PMNs to the
supernatants of AUFP-treated AMs could be
triggered by the mixture of the various lipid
mediators present in the supernatants.
Inhibition of COX in AUFP-treated AMs
abolished the inhibitory effect of the condi-
tioned supernatants on PMN activity (Table
1). Because COX exists in two isoforms,
COX-1 and COX-2, we have used the COX
inhibitors indomethacin and NS 398 in con-
centrations sufficient for each of them to
inhibit both isoforms (27). Among the COX-
dependent metabolites, PGE2 is known to
suppress the respiratory burst activity of
PMA-stimulated PMNs (18), whereas the
5-LO–dependent mediators LTB4 and
5-HETE are able to activate oxygen radical
production (28,29). The 5-LO products are
released from AMs at substantially higher
particle surface areas in the incubations than
the COX products such as PGE2. Because the
inhibitory effect on the PMN activity is seen
with AM-derived supernatants obtained by
both low and high amounts of particle surface
area, we conclude that PGE2 is the predomi-
nant mediator for the response of PMNs in
this system. A possible stimulating effect of
the 5-LO products released at higher particle
surface area seems to be suppressed by PGE2. 
PGE2 is considered an anti-inﬂammatory
mediator because it suppresses the release of
cytokines such as interleukin (IL)-1 and
tumor necrosis factor-α ( TNF-α)  (16,17,
30,31) and downregulates leukotriene synthe-
sis (15). This is consistent with reports docu-
menting that PGE2 upregulates the synthesis
of IL-6, which is known to inhibit the pro-
duction of IL-1β and TNF-α (32), and of IL-
10, which plays a crucial role in terminating
inﬂammatory processes (33). 
We have shown that PGE2 plays a key
regulatory role in the response of AMs to
AUFPs in vitro. We therefore hypothesize
that AM-derived PGE2 downregulates initial
inflammatory reactions, which might be
induced by inhaled AUFPs in vivo to protect
the lungs against inﬂammatory injury and/or
to minimize adverse effects. This protecting
function of PGE2 may be the case for healthy
individuals without symptoms of pulmonary
and cardiovascular diseases. For patients hav-
ing chronic pulmonary problems, the protect-
ing role of PGE2 may be overwhelmed by
ongoing inflammatory processes including
responses of inflammatory cells such as
PMNs to inhaled particles.
In several reports an increased production
of PGE2 was described during in vitro and in
vivo exposure studies with various particulate
matter. Mohr et al. (10) reported that AMs of
rats exposed to silica with a recovery period of
several months showed an increased level of
PGE2 and TXB2 that occurred after the ele-
vated TNF-α release declined. These authors
concluded that AMs of silica-exposed rats dis-
play an enhanced PGE2 production that could
serve anti-inflammatory and immuno-
modulating roles in silicosis. This is in agree-
ment with ﬁndings of Englen et al. (34) who
reported that silica at low doses caused the
release of the COX products PGE2, TXB2,
PGF2, and 12-HHT, whereas the metabolites
of 5-LO were not produced. However, at
higher doses the 5-LO products LTB4 and
5-HETE were also generated accompanied by
an increase in cytotoxicity of the silica parti-
cles. Kuhn et al. (35) showed that AMs of
active coal miners displayed a marked increase
in the production of PGE2, TXB2, IL-1β, and
TNF-α and a reduction of LTB4, compared
to normal volunteers and inactive coal miners.
Despite their occupational exposure to coal
dust, these miners did not have severe respira-
tory symptoms, which might be explained by
their elevated PGE2 levels protecting the lungs
against inﬂammatory injury. AMs exposed in
vitro to freshly fractured coal dust showed ele-
vated levels of PGE2 and TXB2 but normal
levels of LTB4, whereas exposure to silica acti-
vated the production of all three eicosanoids
(36). Taken together these reports show an
activation of the COX pathway with a con-
comitant release of PGE2 by lower amounts
of particulate matter, leading to reduced
inflammatory responses. At higher particle
mass concentrations the proinflammatory
mediator LTB4 is produced in greatest gener-
ation, which also depends on the chemical
composition of the particles. All these find-
ings support our hypothesis that PGE2 pro-
tects against adverse effects of low amounts of
inhaled particles. Interestingly, Oberdörster et
al. (5) have shown that ultraﬁne TiO2 parti-
cles phagocytized by AMs and then instilled
into rats did not elicit the inflammatory
responses caused by the particles alone. This
is consistent with a possible protective role of
PGE2, which downregulates the inflamma-
tory potency of AMs after uptake of particles.
How AUFP–EC and AUFP–TiO2
stimulate AMs to release eicosanoids and
which signal transduction mechanisms are
involved is not currently known. From a cell-
free in vitro system we have obtained evi-
dence that the large surface area of AUFPs
potently oxidizes methionine to methionine
sulfoxide, indicating the formation of oxygen
radicals (37). We therefore suggest that dur-
ing interaction with membranes the oxida-
tive potential of AUFPs may initiate radical
reactions leading to the activation of PLA2,
which hydrolyzes phospholipids with
polyunsaturated fatty acids to protect against
lipid peroxidation (38). AA generated during
hydrolysis of correspondingly substituted
phospholipids may be metabolized by COX,
initiating the formation of PGE2, and by
5-LO, leading to production of 5-HETE and
LTB4. Because these eicosanoids are poten-
tial mediators in stimulating inflammatory
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Table 2. Inﬂuence of particle mass concentration and particle surface area on generation of AA and the COX prod-
ucts PGE2/TXB2 and 12-HHT by canine AMs.
Particle
AUFP–EC AUFP–TiO2 AFP–TiO2
Mass/mL 1 µg 10 µg 100 µg
≅ Surface area/mL 7.5 cm2 5 cm2 6.5 cm2
Initial increase 
(% of controla)( % of controla) (% of controla)
AA 165 ± 30 (3)* 174 ± 17 (3)* 172 ± 23 (4)*
PGE2/TBX2 221 ± 27 (3)* 201 ± 47 (3)* 233 ± 30 (4)*
12-HHT 160 ± 30 (3)* 200 ± 24 (3)* 221 ± 41 (3)*
aControl values are described in legends for Figures 1–3. Asterisks indicate signiﬁcant differences between control cells and particle-
affected cells (*p < 0.05).
Table 3. Inﬂuence of particle mass concentration and particle surface area on generation of the 5-LO products LTB4
and 5-HETE by canine AMs.
Particle
AUFP–EC AUFP–TiO2 AFP–TiO2
Mass/mL 10 µg 32 µg 320 µg
≅ Surface area/mL 75 cm2 16 cm2 21 cm2
Initial increase 
(% of controla)( % of controla) (% of controla)
LTB4 179 ± 31 (5)* 224 ± 71 (7)* 289 ± 92 (5)*
5-HETE 177 ± 57 (5)* 251 ± 63 (5)* 286 ± 84 (5)*
aControl values are described in legends for Figures 1–3. Asterisks indicate signiﬁcant differences between control cells and particle-
affected cells (*p < 0.05).Beck-Speier et al. 
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cells, the preferred generation of PGE2 by
AUFPs may have the effect of downregulat-
ing immune cells and of protecting against
increased oxidant burden. Further studies
should elucidate these molecular mechanisms
in AMs induced by AUFPs, including conse-
quences on gene expression of pro- and anti-
inflammatory cytokines and of protective
and/or repair enzymes. Because the airway
and alveolar epithelia are major targets for
inhaled particles, the responses of epithelial
cells to AUFPs should also be investigated,
including their interactions with AMs. 
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